Literature DB >> 21334998

PIAS3 expression in human gastric carcinoma and its adjacent non-tumor tissues.

Liang-ming Liu1, Ming-guo Yan, Dao-hua Yang, Wei-wei Sun, Ji-xiang Zhang.   

Abstract

OBJECTIVE: PIAS3 is the endogenous inhibitor of STAT3, which has been implicated in the pathogenesis of many cancers. However, the effect of PIAS3 on human tumors remains elusive. The aim of this article is to investigate the expression of PIAS3 in gastric carcinoma and its adjacent non-tumor tissues.
METHODS: Samples were taken from 30 patients with gastric cancer, which included tumor or non-tumor tissues in the excised sections. The expression of PIAS3 protein was detected by immunocytochemistry, and that of mRNA by in situ hybridization. The results were semi-quantitative analyzed by using cell count and color depth to stage.
RESULTS: The expression levels of PIAS3 protein and mRNA were significantly lower in gastric cancerous tissues than in its adjacent non-tumor tissues, and had a close relation with tumor size and differentiation, but not with age, gender and lymphatic metastasis in gastric carcinoma. The more large in size and poorly in differentiation, the more low PIAS3 expression was.
CONCLUSION: Loss of PIAS3 expression may be an important characteristic of gastric cancer and suggest vicious degree of the tumor.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334998     DOI: 10.1016/j.clinre.2010.12.002

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  7 in total

1.  PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer.

Authors:  Jingwu Li; Jianzhong Cui; Jinghua Zhang; Yuanting Liu; Longcai Han; Chunliang Jia; Jingyu Deng; Han Liang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.

Authors:  Xiaoyun Dai; Kwang Seok Ahn; Chulwon Kim; Kodappully Sivaraman Siveen; Tina H Ong; Muthu K Shanmugam; Feng Li; Jizhong Shi; Alan Prem Kumar; Ling Zhi Wang; Boon Cher Goh; Junji Magae; Kam M Hui; Gautam Sethi
Journal:  Mol Oncol       Date:  2015-01-05       Impact factor: 6.603

3.  SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.

Authors:  Seong Won Lee; Moon Hee Lee; Jong Ho Park; Sung Hwan Kang; Hee Min Yoo; Seung Hyun Ka; Young Mi Oh; Young Joo Jeon; Chin Ha Chung
Journal:  EMBO J       Date:  2012-10-23       Impact factor: 11.598

4.  PIAS3/SOCS1-STAT3 axis responses to oxidative stress in hepatocellular cancer cells.

Authors:  Honghua Sun; Yanglong Li; Xianglan Quan; Ning Chen; Xinglin Jin; Wenbiao Jin; Yongmin Jin; Xionghu Shen
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 5.  TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role.

Authors:  Mariano Francesco Caratozzolo; Flaviana Marzano; Francesca Mastropasqua; Elisabetta Sbisà; Apollonia Tullo
Journal:  Genes (Basel)       Date:  2017-11-28       Impact factor: 4.096

6.  Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-κB pathway.

Authors:  Dhanendra Tomar; Lakshmi Sripada; Paresh Prajapati; Rochika Singh; Arun Kumar Singh; Rajesh Singh
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

7.  Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy.

Authors:  Sheau-Fang Yang; Ming-Feng Hou; Fang-Ming Chen; Fu Ou-Yang; Yang-Chang Wu; Chee-Yin Chai; Yao-Tsung Yeh
Journal:  BMC Cancer       Date:  2016-01-14       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.